Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
Pharming Group (NASDAQ:PHAR) has scheduled its second quarter and first half 2025 financial results announcement and business update for July 31, 2025. The company will host a conference call and webcast for analysts and investors at 13:30 CEST/07:30 EDT on the same day.
Participants interested in asking questions during the event must register for the conference call to receive dial-in information and a unique PIN. A webcast option is also available for those who wish to watch the presentation, with a replay to be made available on Pharming's website after the event.
Pharming Group (NASDAQ:PHAR) ha programmato l'annuncio dei risultati finanziari del secondo trimestre e del primo semestre 2025, insieme a un aggiornamento aziendale, per il 31 luglio 2025. La societ脿 terr脿 una conference call e una trasmissione in webcast per analisti e investitori alle 13:30 CEST/07:30 EDT dello stesso giorno.
I partecipanti interessati a porre domande durante l'evento devono registrarsi per la conference call per ricevere le informazioni di accesso e un PIN univoco. 脠 inoltre disponibile un'opzione webcast per chi desidera seguire la presentazione, con una registrazione che sar脿 resa disponibile sul sito web di Pharming dopo l'evento.
Pharming Group (NASDAQ:PHAR) ha programado el anuncio de sus resultados financieros del segundo trimestre y primer semestre de 2025, junto con una actualizaci贸n empresarial, para el 31 de julio de 2025. La compa帽铆a realizar谩 una llamada conferencia y una transmisi贸n por webcast para analistas e inversores a las 13:30 CEST/07:30 EDT del mismo d铆a.
Los participantes interesados en hacer preguntas durante el evento deben registrarse para la llamada conferencia y recibir谩n la informaci贸n para marcar y un PIN 煤nico. Tambi茅n est谩 disponible una opci贸n de webcast para quienes deseen ver la presentaci贸n, con una repetici贸n que se podr谩 consultar en el sitio web de Pharming despu茅s del evento.
Pharming Group (NASDAQ:PHAR)電� 2025雲� 2攵勱赴 氚� 靸侂皹旮� 鞛 瓴瓣臣 氚滍憸鞕� 靷梾 鞐呺嵃鞚错姼毳� 2025雲� 7鞗� 31鞚�鞐� 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 臧欖潃 雮� 13:30 CEST/07:30 EDT鞐� 鞎犽剱毽姢韸胳檧 韴瀽鞛愲ゼ 鞙勴暅 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
鞚措菠韸� 欷� 歆堧鞚� 頃橁碃鞛� 頃橂姅 彀戈皜鞛愲姅 旎嵓霟办姢 旖滌棎 霌彪頃橃棳 鞝勴檾 鞝戩啀 鞝曤炒鞕� 瓿犾湢 PIN鞚� 氚涭晞鞎� 頃╇媹雼�. 霕愴暅 氚滍憸毳� 鞁滌箔頃橁碃鞛� 頃橂姅 攵勲摛鞚� 鞙勴暣 鞗轨簮鞀ろ姼 鞓奠厴鞚� 鞝滉车霅橂┌, 鞚措菠韸� 頉� Pharming 鞗轨偓鞚错姼鞐愳劀 雼れ嫓氤搓赴 靹滊箘鞀るゼ 鞚挫毄頃� 靾� 鞛堨姷雼堧嫟.
Pharming Group (NASDAQ:PHAR) a programm茅 l'annonce de ses r茅sultats financiers du deuxi猫me trimestre et du premier semestre 2025 ainsi qu'une mise 脿 jour commerciale pour le 31 juillet 2025. La soci茅t茅 organisera une conf茅rence t茅l茅phonique et une webdiffusion pour les analystes et investisseurs 脿 13h30 CEST/07h30 EDT le m锚me jour.
Les participants souhaitant poser des questions lors de l'茅v茅nement doivent s'inscrire 脿 la conf茅rence t茅l茅phonique afin de recevoir les informations d'appel et un code PIN unique. Une option webdiffusion est 茅galement disponible pour ceux qui souhaitent suivre la pr茅sentation, avec une rediffusion accessible sur le site web de Pharming apr猫s l'茅v茅nement.
Pharming Group (NASDAQ:PHAR) hat die Bekanntgabe der Finanzergebnisse f眉r das zweite Quartal und das erste Halbjahr 2025 sowie ein Gesch盲ftsupdate f眉r den 31. Juli 2025 geplant. Das Unternehmen wird am selben Tag um 13:30 CEST/07:30 EDT eine Telefonkonferenz und einen Webcast f眉r Analysten und Investoren veranstalten.
Teilnehmer, die w盲hrend der Veranstaltung Fragen stellen m枚chten, m眉ssen sich f眉r die Telefonkonferenz registrieren, um Einwahlinformationen und eine individuelle PIN zu erhalten. F眉r diejenigen, die die Pr盲sentation verfolgen m枚chten, steht au脽erdem eine Webcast-Option zur Verf眉gung, deren Aufzeichnung nach der Veranstaltung auf der Pharming-Website abrufbar sein wird.
- None.
- None.
Leiden, the Netherlands, July 17, 2025:听Pharming Group N.V. (鈥淧harming鈥�) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second quarter and first half 2025 and provide a business update on Thursday, July 31, 2025.
Management will host a conference call and webcast for analysts and investors on the same day at 13:30 CEST/07:30 am EDT.
To participate in the conference call or to watch the live webcast, please register in advance using the links below.
Conference call registration:
Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.听
Please note, the Company will only take questions from dial-in attendees.
Webcast registration:听
The webcast will also be accessible on the Pharming website at听, and a replay will be available shortly after the event.
听
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit and find us on .
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E:
FTI Consulting, London, UK
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E:
Attachment
FAQ
When will Pharming Group (PHAR) release Q2 and H1 2025 financial results?
What time is Pharming Group's Q2 2025 earnings call?
How can investors participate in Pharming Group's Q2 2025 earnings call?
Where can I find the replay of Pharming Group's Q2 2025 earnings call?
